Global Partnership with Duracell Batteries to Power New, Innovative Health Monitoring Technology

Use Case: Women's Health

Duracell® batteries will be integrated into KIFFIK Biomonitoring Devices, such as health monitors, that detect various biomarkers in the body.

[Providence, RI, 01/29/2025] – KIFFIK Biomedical and Duracell U.S. Operations, Inc. (“Duracell”) have agreed to collaborate and assess the integration of long-lasting, efficient power solutions with cutting-edge biomonitoring technology. This is good news for patients and the public communities, as the partnership’s goal is to enhance the precision and dependability of health monitoring systems around the globe, ultimately benefitting users in hospitals, high-performance sports, the military, and at home with more reliable health data through continuous sampling and a better user experience.

"We are thrilled to announce our partnership with Duracell, a company that shares our commitment to innovation and excellence. Integrating Duracell's trusted battery technology into our biomonitoring devices represents a significant leap forward in our mission to advance health monitoring solutions. This collaboration underscores our dedication to delivering superior, dependable products that improve the quality of life for individuals worldwide."

George Cagna

CEO, KIFFIK Biomedical

Duracell is equally excited about this partnership and the potential it holds for advancing healthcare technology.

"We are constantly looking to partner with visionary companies that drive progress and innovation. Through this partnership with KIFFIK Biomedical, we are contributing to our expertise in power solutions to help enable KIFFIK Biomedical's biomonitoring technologies, and the associated potential benefits."

Gulhande Sanay

President Future Innovation, Duracel®

About KIFFIK Biomedical

KIFFIK Biomedical is unlocking a new era in disease detection and biomarker assessment through its revolutionary wearable interstitial fluid (ISF) monitoring technology. The “KIFFIK Lab” delivers non-invasive, real-time access to the body’s untapped biological data, enabling earlier cancer detection and unparalleled insights into disease progression. KIFFIK has the potential to reshape and pave the way for future early disease screening, biomarker discovery, and drug development, redefining patient outcomes and the boundaries of medical science. Learn more →

About Duracell

Duracell is a global leader in power solutions, renowned for its high-performance batteries and commitment to quality and reliability to consumers and partners, along with driving positive impact on environment and the communities the business operates in. With a legacy of innovation and excellence, Duracell provides consumers and businesses with trusted power solutions that meet the demands of modern technology and everyday life. For more information, visit Duracell’s Website →

Use Case: Military & PolyTrauma

Field-ready diagnostics for
high-consequence decisions.

The challenge.

In military and trauma settings, rapid diagnosis can mean the difference between life and loss. Yet current tools often require centralized labs, invasive procedures, or lag-time results — none of which are ideal in field, combat, or mass casualty environments.

The opportunity.

KIFFIK’s non-invasive ISF platform could deliver real-time biomarker data directly at the point of injury — enabling rapid triage, injury stratification, and early detection of complications like internal bleeding, systemic inflammation, or infection. Designed for portability and ease of use, the platform can support frontline teams with fast, actionable insight.

Clinical application:

Triage of blast injuries, blunt trauma, and polytrauma
Early detection of inflammatory cascade and internal bleeding
Remote deployment in field hospitals, medevac, or battlefield medicine

Potential biomoarkers:

Interleukin-6 (IL-6)
S100B (neurotrauma indicator)
Lactate (tissue hypoxia)
D-dimer (coagulation dysfunction)
Myoglobin (muscle damage)
TNF-α (systemic inflammation)

When every second counts, insight can’t wait for the hospital. KIFFIK’s platform is designed to move with the mission — delivering data where it’s needed most.

Use Case: Prostate Cancer

Duracell® batteries will be integrated into KIFFIK Biomonitoring Devices, such as health monitors, that detect various biomarkers in the body.

[Providence, RI, 01/29/2025] – KIFFIK Biomedical and Duracell U.S. Operations, Inc. (“Duracell”) have agreed to collaborate and assess the integration of long-lasting, efficient power solutions with cutting-edge biomonitoring technology. This is good news for patients and the public communities, as the partnership’s goal is to enhance the precision and dependability of health monitoring systems around the globe, ultimately benefitting users in hospitals, high-performance sports, the military, and at home with more reliable health data through continuous sampling and a better user experience.

"We are thrilled to announce our partnership with Duracell, a company that shares our commitment to innovation and excellence. Integrating Duracell's trusted battery technology into our biomonitoring devices represents a significant leap forward in our mission to advance health monitoring solutions. This collaboration underscores our dedication to delivering superior, dependable products that improve the quality of life for individuals worldwide."

George Cagna

CEO, KIFFIK Biomedical

Duracell is equally excited about this partnership and the potential it holds for advancing healthcare technology.

"We are constantly looking to partner with visionary companies that drive progress and innovation. Through this partnership with KIFFIK Biomedical, we are contributing to our expertise in power solutions to help enable KIFFIK Biomedical's biomonitoring technologies, and the associated potential benefits."

Gulhande Sanay

President Future Innovation, Duracel®

About KIFFIK Biomedical

KIFFIK Biomedical is unlocking a new era in disease detection and biomarker assessment through its revolutionary wearable interstitial fluid (ISF) monitoring technology. The “KIFFIK Lab” delivers non-invasive, real-time access to the body’s untapped biological data, enabling earlier cancer detection and unparalleled insights into disease progression. KIFFIK has the potential to reshape and pave the way for future early disease screening, biomarker discovery, and drug development, redefining patient outcomes and the boundaries of medical science. Learn more →

About Duracell

Duracell is a global leader in power solutions, renowned for its high-performance batteries and commitment to quality and reliability to consumers and partners, along with driving positive impact on environment and the communities the business operates in. With a legacy of innovation and excellence, Duracell provides consumers and businesses with trusted power solutions that meet the demands of modern technology and everyday life. For more information, visit Duracell’s Website →

ISF Research & Biomarker Discovery

Duracell® batteries will be integrated into KIFFIK Biomonitoring Devices, such as health monitors, that detect various biomarkers in the body.

[Providence, RI, 01/29/2025] – KIFFIK Biomedical and Duracell U.S. Operations, Inc. (“Duracell”) have agreed to collaborate and assess the integration of long-lasting, efficient power solutions with cutting-edge biomonitoring technology. This is good news for patients and the public communities, as the partnership’s goal is to enhance the precision and dependability of health monitoring systems around the globe, ultimately benefitting users in hospitals, high-performance sports, the military, and at home with more reliable health data through continuous sampling and a better user experience.

"We are thrilled to announce our partnership with Duracell, a company that shares our commitment to innovation and excellence. Integrating Duracell's trusted battery technology into our biomonitoring devices represents a significant leap forward in our mission to advance health monitoring solutions. This collaboration underscores our dedication to delivering superior, dependable products that improve the quality of life for individuals worldwide."

George Cagna

CEO, KIFFIK Biomedical

Duracell is equally excited about this partnership and the potential it holds for advancing healthcare technology.

"We are constantly looking to partner with visionary companies that drive progress and innovation. Through this partnership with KIFFIK Biomedical, we are contributing to our expertise in power solutions to help enable KIFFIK Biomedical's biomonitoring technologies, and the associated potential benefits."

Gulhande Sanay

President Future Innovation, Duracel®

About KIFFIK Biomedical

KIFFIK Biomedical is unlocking a new era in disease detection and biomarker assessment through its revolutionary wearable interstitial fluid (ISF) monitoring technology. The “KIFFIK Lab” delivers non-invasive, real-time access to the body’s untapped biological data, enabling earlier cancer detection and unparalleled insights into disease progression. KIFFIK has the potential to reshape and pave the way for future early disease screening, biomarker discovery, and drug development, redefining patient outcomes and the boundaries of medical science. Learn more →

About Duracell

Duracell is a global leader in power solutions, renowned for its high-performance batteries and commitment to quality and reliability to consumers and partners, along with driving positive impact on environment and the communities the business operates in. With a legacy of innovation and excellence, Duracell provides consumers and businesses with trusted power solutions that meet the demands of modern technology and everyday life. For more information, visit Duracell’s Website →

Use Case: Sepsis